TCMBANKIN002024 |
triptobenzene B |
|
C20H30O2 |
302.5 g/mol |
CC(C)C1=C(C2=C(C=C1)C3(CCC(C(C3CC2)(C)C)O)C)O |
TCMBANKIN003737 |
triptofordin C-2 |
|
|
|
|
TCMBANKIN011835 |
3,9-dihydroxymegastigman-5-ene |
|
|
|
|
TCMBANKIN017802 |
pterodontriol B |
|
|
|
|
TCMBANKIN019409 |
pubinernoid A |
|
|
|
|
TCMBANKIN021014 |
(1S,4S,5R,6R,7R,9S,10S)-6,9-dibenzoyloxy-1-(3-furoyloxy)-4-hydroxy-dihydro-β-agarofuran |
|
|
|
|
TCMBANKIN021464 |
regelin d |
methyl (2S,4aR,6bR,12aR)-4-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-10-oxo-3,4,5,6,6a,7,8,8a,11,12,13,14b-dodecahydro-1H-picene-2-carboxylate; AC1NSZZZ |
C31H48O4 |
484.7 g/mol |
CC1(C2CCC3(C(C2(CCC1=O)C)CC=C4C3(CCC5(C4CC(CC5O)(C)C(=O)OC)C)C)C)C |
TCMBANKIN023425 |
triptoquinone F |
|
C20H26O4 |
|
CC(C)C1=CC(=O)C2=C(C1=O)CCC3C2(CCCC3(C)C(=O)O)C |
TCMBANKIN026377 |
triptoquinone B |
|
C20H26O4 |
330.4 g/mol |
CC(C)C1=CC(=O)C2=C(C1=O)CCC3C2(CCC(=O)C3(C)CO)C |
TCMBANKIN029793 |
alangionoside J |
|
C19H36O7 |
|
CC1CC(CC(C1CCC(C)O)(C)C)OC2C(C(C(C(O2)CO)O)O)O |
TCMBANKIN032344 |
triptoquinone A |
|
C20H24O4 |
328.4 g/mol |
CC1=C(CCC2(C1CCC3=C2C(=O)C=C(C3=O)C(C)C)C)C(=O)O |
TCMBANKIN035328 |
triptoquinone D |
|
C20H28O3 |
|
CC(C)C1=CC(=O)C2=C(C1=O)CCC3C2(CCCC3(C)CO)C |
TCMBANKIN037800 |
orthosphenic acid |
orthosphenicacid |
C30H48O5 |
489 |
[C@]1([H])(O[H])C([H])([H])[C@@]([H])([C@](C([H])([H])[H])(C([H])([H])C([H])([H])[C@@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@](C(O[H])=O)(C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]2(C([H])([H])[H]
)C([H])([H])C3([H])[H])[C@]34C([H])([H])[H])[C@@]4([H])C([H])([H])C5([H])[H])[C@@]5(C([H])([H])O6)[C@@]([H])(C([H])([H])[H])[C@]16O[H] |
TCMBANKIN042151 |
ergosterol peroxide |
ergosterol peroxide; 2061-64-5; ergosterolperoxide; dimethyl-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl][?]ol; (3.beta.,5.alpha.,8.alpha.,22E)-5,8-Epidioxyergosta-6,22-dien-3-ol |
C56H86O2 |
791 |
O([C@]1([H])C([H])([H])C([C@@](C([H])([H])[H])([C@]([H])(C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C([H])([H])[H])\C([H])=C([H])\[C@@]([H])(C([H])(C([H])([H])[H])C([H])([H])[H])C
([H])([H])[H])C([H])([H])C2([H])[H])[C@]23[H])C3=C4[H])C([H])([H])C1([H])[H])=C4[H])O[C@]5([H])C([H])([H])C([C@@](C([H])([H])[H])([C@]([H])(C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([
H])(C([H])([H])[H])\C([H])=C([H])\[C@@]([H])(C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])C6([H])[H])[C@]67[H])C7=C8[H])C([H])([H])C5([H])[H])=C8[H] |
TCMBANKIN044215 |
dulcioic acid |
|
C30H48O3 |
456.7 g/mol |
CC1C(CCC2(C1C3=CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)C)C(=O)O |
TCMBANKIN045404 |
salaspermic acid |
salaspermicacid |
C30H48O4 |
473 |
C1([H])([H])C([H])([H])[C@@]([H])([C@](C([H])([H])[H])(C([H])([H])C([H])([H])[C@@](C([H])([H])[H])([C@]([H])(C([H])([H])[C@@](C(O[H])=O)(C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]2(C([H])([H])[H])C([H
])([H])C3([H])[H])[C@]34C([H])([H])[H])[C@]4([H])C([H])([H])C5([H])[H])[C@@]5(C([H])([H])O6)[C@@]([H])(C([H])([H])[H])[C@]16O[H] |
TCMBANKIN046467 |
Triptocalline A |
201534-10-3; D02DYB; Triptocalline A; TriptocallineA; ZINC40378969 |
|
442.6 g/mol |
|
TCMBANKIN046768 |
wilforlide B |
Wilforlide B; wilforlide b |
C30H44O3 |
453 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])=C([C@]([H])(C([H])([H])[C@@](C(=O)O2)(C([H])([H])[H])C([H])([H])[C@]23[H])[C@@]3(C([H])([H])[H])C([H])([H])C4([H])[H])[C@]45C([
H])([H])[H])[C@@]5(C([H])([H])[H])C([H])([H])C6([H])[H])[C@@]6([H])C(C([H])([H])[H])(C([H])([H])[H])C1=O |
TCMBANKIN059149 |
Ergosterol peroxide |
2061-64-5; NSC31324; Ergosterol peroxide; 5.alpha.,8.alpha.-Ergosta-6,22-dien-3.beta.-ol, 5,8-epidioxy-; ERGOSTEROL-5,8-PEROXIDE; Ergosterol 5.alpha.,8.alpha.-epidioxide; Ergosta-6,22-dien-3-ol, 5,8-epidioxy-, (3.beta.,5.alpha.,8.alpha.,22E)-; Ergosterol endoperoxide; (3β,5α,8α,22E,24R)-5,8-Epidioxyergosta-6,22-dien-3-ol; 5,8-epidioxyergosta-6,22-dien-3-ol; Peroxyergosterol; ergosterol peroxide; 2061-64-5; ergosterolperoxide; dimethyl-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl][?]ol; (3.beta.,5.alpha.,8.alpha.,22E)-5,8-Epidioxyergosta-6,22-dien-3-ol |
C28H44O3 |
428.6 g/mol |
CC(C)C(C)C=CC(C)C1CCC2C1(CCC3C24C=CC5(C3(CCC(C5)O)C)OO4)C |
TCMBANKIN059539 |
abrusgenicacid |
|
C30H48O4 |
472.7 g/mol |
CC1(C2CCC3(C(C2(CCC1O)C)CC=C4C3(CCC5(C4CC(CC5O)(C)C(=O)O)C)C)C)C |
TCMBANKIN059540 |
WILFORLIDE A |
|
C30H46O3 |
454.7 g/mol |
CC1(C2CCC3(C(C2(CCC1O)C)CC=C4C3(CCC5(C4CC6(CC5OC6=O)C)C)C)C)C |
TCMBANKIN059689 |
tripterine |
|
C29H38O4 |
450.61 |
CC1=C(C(=O)C=C2C1=CC=C3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C)O |
TCMBANKIN059707 |
linarionoside A;linarionoside a;(3r,9s)-megastigman-5-en-3,9-diol-3-o-β-d-glucopyranoside |
|
C19H34O7 |
|
CC1=C(C(CC(C1)OC2C(C(C(C(O2)CO)O)O)O)(C)C)CCC(C)O |
TCMBANKIN060139 |
maytenonic acid |
|
C30H48O3 |
456.7 g/mol |
CC1C(=O)CCC2C1(CCC3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C)C |
TCMBANKIN060434 |
tingenin |
|
C28H36O4 |
436.6 g/mol |
CC1CC2C(CCC3(C2(CCC4(C3=CC=C5C4=CC(=O)C(=C5C)O)C)C)C)(C(C1=O)O)C |
TCMBANKIN060693 |
Sitogluside |
|
C35H60O6 |
576.85g/mol |
CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C |